Ami Fadia

Stock Analyst at Needham

(1.13)
# 2047
Out of 5,386 analysts
502
Total ratings
Success rate
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Reiterates: Buy
30 30
22.09 35.81% 10 Jun 26, 2025
RVMD Revolution Medicines
Reiterates: Buy
57 57
36.92 54.39% 24 Jun 24, 2025
IMRX Immuneering
Reiterates: Buy
9 9
3.52 155.68% 17 Jun 18, 2025
COGT Cogent Biosciences
Reiterates: Hold
n/a
n/a n/a 23 Jun 17, 2025
SAGE Sage Therapeutics
Reiterates: Hold
n/a
n/a n/a 22 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
42.97 86.18% 12 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 41 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
202 202
107.03 88.73% 32 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
153 150
103.39 45.08% 15 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
130 130
128.07 1.51% 31 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
13.14 166.36% 1 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
28.8 56.25% 1 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
75 88
52.94 66.23% 29 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.77 549.35% 9 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
9.21 106.3% 36 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 27
6.47 317.31% 20 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49 49
31.98 53.22% 37 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 139
125.44 10.81% 14 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 29
7.23 301.11% 20 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 27 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 7 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
n/a
n/a n/a 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
n/a n/a 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
28 26
n/a n/a 6 Feb 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
240 320
15.66 1943.42% 2 Feb 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
63 75
23.46 219.69% 7 Jan 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 5
n/a n/a 2 Jan 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
10 14
n/a n/a 3 Oct 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
15 23
1 2150% 4 Oct 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 63
26.55 137.29% 4 Sep 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 2
n/a n/a 8 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 10
n/a n/a 2 Jul 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
24
n/a n/a 8 Jan 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 20
n/a n/a 2 Sep 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
12 5
3.85 29.87% 2 Jan 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
n/a
n/a n/a 7 Oct 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 5 Jan 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
22
2.13 932.86% 4 Jan 3, 2018